Article History
Received: 23 October 2018
Accepted: 18 March 2019
First Online: 14 May 2019
Compliance with ethical standards
:
: Linda Vahdat has performed consulting for Berg Pharma, Seattle Genetics, Athenex, and Eisai and has received clinical trial research funding from Genentech and Immunomedics. Dimitris Bertsimas and John Silberholz declare that they have no conflict of interest.
: This article does not contain any studies with human participants or animals performed by any of the authors.